{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:31:40Z","timestamp":1793035900638,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1208\/s12249-018-0985-4","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T15:24:32Z","timestamp":1525101872000},"page":"1730-1743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Formulation Development and Evaluation of Diphenhydramine Nasal Nano-Emulgel"],"prefix":"10.1208","volume":"19","author":[{"given":"Hina","family":"Javed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Nisar Hussain","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqan Muhammad","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"985_CR1","doi-asserted-by":"crossref","unstructured":"Kim D-D. In vitro cellular models for nasal drug absorption studies. In: Ehrhardt C, Kim KJ, editors. Drug absorption studies. Boston: Springer; 2008. p. 216\u2013234.","DOI":"10.1007\/978-0-387-74901-3_9"},{"issue":"1","key":"985_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jps.21793","volume":"99","author":"NR Mathias","year":"2010","unstructured":"Mathias NR, Hussain MA. Non-invasive systemic drug delivery: developability considerations for alternate routes of administration. J Pharm Sci. 2010;99(1):1\u201320.","journal-title":"J Pharm Sci"},{"issue":"1","key":"985_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","volume":"337","author":"HR Costantino","year":"2007","unstructured":"Costantino HR, et al. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm. 2007;337(1):1\u201324.","journal-title":"Int J Pharm"},{"issue":"1","key":"985_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0169-409X(97)00066-5","volume":"29","author":"MD Donovan","year":"1998","unstructured":"Donovan MD, Huang Y. Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption. Adv Drug Deliv Rev. 1998;29(1):147\u201355.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"985_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/10717544.2013.849778","volume":"21","author":"UC Galgatte","year":"2014","unstructured":"Galgatte UC, Kumbhar AB, Chaudhari PD. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation. Drug Deliv. 2014;21(1):62\u201373.","journal-title":"Drug Deliv"},{"key":"985_CR6","doi-asserted-by":"crossref","unstructured":"Bitter C, Suter-Zimmermann K, Surber C. Nasal drug delivery in humans. In: Surber C, Elsner P, Farage MA, editors. Topical applications and the mucosa. Basel: Karger Publishers; 2011. p. 20\u201335.","DOI":"10.1159\/000321044"},{"issue":"2","key":"985_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","volume":"14","author":"BW Barry","year":"2001","unstructured":"Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101\u201314.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"985_CR8","first-page":"899","volume":"5","author":"LR Samant","year":"2012","unstructured":"Samant LR, Bhaskar A. Transdermal drug delivery system: review. J Pharm Res Vol. 2012;5(2):899\u2013900.","journal-title":"J Pharm Res Vol"},{"issue":"5","key":"985_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/jps.2600780502","volume":"78","author":"YW Chien","year":"1989","unstructured":"Chien YW, Banga AK. Iontophoretic (transdermal) delivery of drugs: overview of historical development. J Pharm Sci. 1989;78(5):353\u20134.","journal-title":"J Pharm Sci"},{"key":"985_CR10","first-page":"197","volume":"119","author":"KR Brain","year":"2002","unstructured":"Brain KR, Walters KA, Watkinson AC. Methods for studying percutaneous absorption. Drugs and the Pharmaceutical Sciences. 2002;119:197\u2013270.","journal-title":"Drugs and the Pharmaceutical Sciences."},{"issue":"3","key":"985_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/03639040701662644","volume":"34","author":"C-W Cho","year":"2008","unstructured":"Cho C-W, Choi J-S, Shin S-C. Development of the ambroxol gels for enhanced transdermal delivery. Drug Dev Ind Pharm. 2008;34(3):330\u20135.","journal-title":"Drug Dev Ind Pharm"},{"key":"985_CR12","unstructured":"Steiger M. Topical emulsion-gel composition comprising diclofenac sodium. 2010. Google Patents."},{"issue":"3","key":"985_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1208\/aapsj060326","volume":"6","author":"MI Mohamed","year":"2004","unstructured":"Mohamed MI. Optimization of chlorphenesin emulgel formulation. AAPS J. 2004;6(3):81\u20137.","journal-title":"AAPS J"},{"issue":"1","key":"985_CR14","first-page":"118","volume":"4","author":"P Peneva","year":"2014","unstructured":"Peneva P, et al. In vitro survey of Ketoprofen release from emulgels. Medicine. 2014;4(1):118\u201321.","journal-title":"Medicine"},{"issue":"1","key":"985_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jsps.2011.08.001","volume":"20","author":"R Khullar","year":"2012","unstructured":"Khullar R, et al. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharm J. 2012;20(1):63\u20137.","journal-title":"Saudi Pharm J"},{"issue":"1","key":"985_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5138\/ijdd.2010.0975.0215.02014","volume":"2","author":"S Mandal","year":"2010","unstructured":"Mandal S, Mandal SS, Sawant KK. Design and development of microemulsion drug delivery system of atorvastatin and study its intestinal permeability in rats. Int J Drug Deliv. 2010;2(1):69\u201375.","journal-title":"Int J Drug Deliv"},{"issue":"3","key":"985_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jpainsymman.2006.11.005","volume":"33","author":"SP Stanos","year":"2007","unstructured":"Stanos SP. Topical agents for the management of musculoskeletal pain. J Pain Symptom Manag. 2007;33(3):342\u201355.","journal-title":"J Pain Symptom Manag"},{"key":"985_CR18","doi-asserted-by":"crossref","unstructured":"Banker GS. The theory and practice of industrial pharmacy. Vol. 1. Edited by Leon Lachman, Herbert A. Lieberman, and Joseph L. Kanig. Lea & Febiger, Philadelphia, PA 19106, 1970. xii\u2009+\u2009811\u00a0pp. 15.5\u00d7 23\u00a0cm. Price $24.50. J Pharm Sci. 1970;59(10):1531\u20131.","DOI":"10.1002\/jps.2600591046"},{"issue":"10","key":"985_CR19","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","volume":"30","author":"CD Chapman","year":"2013","unstructured":"Chapman CD, et al. Intranasal treatment of central nervous system dysfunction in humans. Pharm Res. 2013;30(10):2475\u201384.","journal-title":"Pharm Res"},{"issue":"3","key":"985_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2165\/00126839-200708030-00001","volume":"8","author":"FW Merkus","year":"2007","unstructured":"Merkus FW, van den Berg MP. Can nasal drug delivery bypass the blood-brain barrier? Drugs R D. 2007;8(3):133\u201344.","journal-title":"Drugs R D"},{"issue":"1","key":"985_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(97)00058-6","volume":"29","author":"N Mygind","year":"1998","unstructured":"Mygind N, Dahl R. Anatomy, physiology and function of the nasal cavities in health and disease. Adv Drug Deliv Rev. 1998;29(1):3\u201312.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"985_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0378-5173(99)00055-1","volume":"181","author":"AK Levang","year":"1999","unstructured":"Levang AK, Zhao K, Singh J. Effect of ethanol\/propylene glycol on the in vitro percutaneous absorption of aspirin, biophysical changes and macroscopic barrier properties of the skin. Int J Pharm. 1999;181(2):255\u201363.","journal-title":"Int J Pharm"},{"key":"985_CR23","volume-title":"The HLB system: a time-saving guide to emulsifier selection","author":"I Americas","year":"1984","unstructured":"Americas I. The HLB system: a time-saving guide to emulsifier selection. Wilmington: ICI Americas, Incorporated; 1984."},{"key":"985_CR24","first-page":"311","volume":"1","author":"WC Griffin","year":"1946","unstructured":"Griffin WC. Classification of surface-active agents by \u201cHLB\u201d. J Soc Cosmet Chem. 1946;1:311\u201326.","journal-title":"J Soc Cosmet Chem"},{"key":"985_CR25","first-page":"26","volume":"65","author":"WC Griffin","year":"1955","unstructured":"Griffin WC. Calculation of HLB values of non-ionic surfactants. Am Perfume Essent Oil Rev. 1955;65:26\u20139.","journal-title":"Am Perfume Essent Oil Rev"},{"issue":"6","key":"985_CR26","first-page":"137","volume":"4","author":"G Sowjanya","year":"2012","unstructured":"Sowjanya G, Bandhavi P. Nanoemulsions an emerging trend: a review. IJPRD. 2012;4(6):137\u201352.","journal-title":"IJPRD"},{"issue":"11","key":"985_CR27","first-page":"853","volume":"66","author":"M Ghica","year":"2011","unstructured":"Ghica M, et al. Design and optimization of some collagen-minocycline based hydrogels potentially applicable for the treatment of cutaneous wound infections. Die Pharmazie-Int J Pharm Sci. 2011;66(11):853\u201361.","journal-title":"Die Pharmazie-Int J Pharm Sci"},{"issue":"1","key":"985_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijpharm.2007.01.033","volume":"338","author":"J-S Chang","year":"2007","unstructured":"Chang J-S, et al. Formulation optimization of meloxicam sodium gel using response surface methodology. Int J Pharm. 2007;338(1):48\u201354.","journal-title":"Int J Pharm"},{"issue":"2","key":"985_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/10717540500313331","volume":"13","author":"Y Samat\u0131","year":"2006","unstructured":"Samat\u0131 Y, Y\u00fcksel N, Tarimc\u0131 N. Preparation and characterization of poly (D, L-lactic-co-glycolic acid) microspheres containing flurbiprofen sodium. Drug Deliv. 2006;13(2):105\u201311.","journal-title":"Drug Deliv"},{"issue":"1","key":"985_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijpharm.2007.08.030","volume":"350","author":"S Wang","year":"2008","unstructured":"Wang S, Guo S, Cheng L. Disodium norcantharidate loaded poly (\u025b-caprolactone) microspheres: I. Preparation and evaluation. Int J Pharm. 2008;350(1):130\u20137.","journal-title":"Int J Pharm"},{"issue":"27","key":"985_CR31","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1016\/S0142-9612(03)00419-8","volume":"24","author":"G Ruan","year":"2003","unstructured":"Ruan G, Feng S-S. Preparation and characterization of poly (lactic acid)\u2013poly (ethylene glycol)\u2013poly (lactic acid)(PLA\u2013PEG\u2013PLA) microspheres for controlled release of paclitaxel. Biomaterials. 2003;24(27):5037\u201344.","journal-title":"Biomaterials"},{"issue":"2","key":"985_CR32","first-page":"28","volume":"2","author":"AMS NM","year":"2012","unstructured":"NM AMS, Abd El Gawad N. Preparation and characterization of benzophenone-3 loaded polymeric nanoparticles of lactide-co-\u025b-caprolactone as drug carriers. J Pharm Res Opin. 2012;2(2):28\u201341.","journal-title":"J Pharm Res Opin"},{"issue":"3","key":"985_CR33","first-page":"310","volume":"4","author":"J Baibhav","year":"2012","unstructured":"Baibhav J, et al. Development and characterization of clarithromycin emulgel for topical delivery. Int J Drug Dev Res. 2012;4(3):310\u201323.","journal-title":"Int J Drug Dev Res"},{"issue":"4","key":"985_CR34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3797\/scipharm.1206-09","volume":"80","author":"NK Thakur","year":"2012","unstructured":"Thakur NK, et al. Formulation and characterization of benzoyl peroxide gellified emulsions. Sci Pharm. 2012;80(4):1045\u201360.","journal-title":"Sci Pharm"},{"issue":"2","key":"985_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/10717540500313356","volume":"13","author":"J Varshosaz","year":"2006","unstructured":"Varshosaz J, Tavakoli N, Eram SA. Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets. Drug Deliv. 2006;13(2):113\u20139.","journal-title":"Drug Deliv"},{"issue":"2","key":"985_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3109\/03639045.2011.595416","volume":"38","author":"A Badshah","year":"2012","unstructured":"Badshah A, et al. Once daily controlled release matrix tablet of prochlorperazine maleate: Influence of Ethocel\u00ae and\/or Methocel\u00ae on in vitro drug release and bioavailability. Drug Dev Ind Pharm. 2012;38(2):190\u20139.","journal-title":"Drug Dev Ind Pharm"},{"issue":"8","key":"985_CR37","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3109\/03639049109043842","volume":"17","author":"A Babar","year":"1991","unstructured":"Babar A, Bhandari R, Plakogiannis F. In-vitro release studies op chlorpheniramine maleate from topical bases using cellulose membrane and hairless mouse skin. Drug Dev Ind Pharm. 1991;17(8):1027\u201340.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"985_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263\u201371.","journal-title":"AAPS J"},{"issue":"1","key":"985_CR39","first-page":"27","volume":"12","author":"S Shah","year":"2013","unstructured":"Shah S, et al. Effect of permeation enhancers on the release behavior and permeation kinetics of novel tramadol lotions. Trop J Pharm Res. 2013;12(1):27\u201332.","journal-title":"Trop J Pharm Res"},{"issue":"2","key":"985_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4314\/tjpr.v14i2.2","volume":"14","author":"RK Ayoub","year":"2015","unstructured":"Ayoub RK, et al. Formulation and permeation kinetic studies of flurbiprofen gel. Trop J Pharm Res. 2015;14(2):195\u2013203.","journal-title":"Trop J Pharm Res"},{"issue":"6","key":"985_CR41","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19(6):716\u201323.","journal-title":"IEEE Trans Autom Control"},{"issue":"1","key":"985_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijpharm.2010.08.006","volume":"399","author":"Y Obata","year":"2010","unstructured":"Obata Y, et al. A statistical approach to the development of a transdermal delivery system for ondansetron. Int J Pharm. 2010;399(1):87\u201393.","journal-title":"Int J Pharm"},{"issue":"12","key":"985_CR43","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3109\/03639040903025848","volume":"35","author":"SNH Shah","year":"2009","unstructured":"Shah SNH, et al. Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology. Drug Dev Ind Pharm. 2009;35(12):1470\u20138.","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"985_CR44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1248\/yakushi.129.569","volume":"129","author":"RC Narayana","year":"2009","unstructured":"Narayana RC, et al. Formulation and in vitro evaluation of in situ gels containing secnidazole for vaginitis. Yakugaku Zasshi. 2009;129(5):569\u201374.","journal-title":"Yakugaku Zasshi"},{"issue":"2","key":"985_CR45","first-page":"464","volume":"20","author":"SNH Shah","year":"2012","unstructured":"Shah SNH. Developing an efficacious diclofenac diethylamine transdermal formulation. J Food Drug Anal. 2012;20(2):464\u201370.","journal-title":"J Food Drug Anal"},{"key":"985_CR46","unstructured":"El-Houssieny BM, Hamouda HM. Formulation and evaluation of clotrimazole from pluronic F 127 gels. Drug Discov Ther. 2010:4(1)."},{"issue":"5","key":"985_CR47","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/BF01153516","volume":"11","author":"DT Moran","year":"1982","unstructured":"Moran DT, et al. The fine structure of the olfactory mucosa in man. J Neurocytol. 1982;11(5):721\u201346.","journal-title":"J Neurocytol"},{"key":"985_CR48","doi-asserted-by":"crossref","unstructured":"Pottorf RS. Peptide-based drug design: controlling transport and metabolism In: Taylor MD, Amidon GL, editors. Washington, DC: American Chemical Society; 1995. xviii\u2009+\u2009567\u00a0pp. 18.5\u00d7 26\u00a0cm. $99.95. ACS Publications; 1996.","DOI":"10.1021\/jm950847j"},{"issue":"1","key":"985_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijpharm.2016.05.065","volume":"514","author":"J Hadgraft","year":"2016","unstructured":"Hadgraft J, Lane ME. Advanced topical formulations (ATF). Int J Pharm. 2016;514(1):52\u20137.","journal-title":"Int J Pharm"},{"issue":"1","key":"985_CR50","first-page":"99","volume":"46","author":"S Waheed","year":"2014","unstructured":"Waheed S, et al. Comparative efficiency of propylene glycol and polyethylene glycol in enhancing percutaneous absorption and release of a drug through silicone membrane and rat skin. Pak J Zool. 2014;46(1):99\u2013106.","journal-title":"Pak J Zool"},{"issue":"1","key":"985_CR51","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1939-4551-4-S1-S1","volume":"4","author":"FM Baroody","year":"2011","unstructured":"Baroody FM, Naclerio RM. Nasal-ocular reflexes and their role in the management of allergic rhinoconjunctivitis with intranasal steroids. World Allergy Organ J. 2011;4(1):S1.","journal-title":"World Allergy Organ J"},{"key":"985_CR52","doi-asserted-by":"crossref","unstructured":"Broide DH. Allergic rhinitis: pathophysiology. In: Allergy and asthma proceedings, OceanSide Publications, Inc. 2010.","DOI":"10.2500\/aap.2010.31.3388"},{"issue":"1","key":"985_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.902970102","volume":"297","author":"EE Morrison","year":"1990","unstructured":"Morrison EE, Costanzo RM. Morphology of the human olfactory epithelium. J Comp Neurol. 1990;297(1):1\u201313.","journal-title":"J Comp Neurol"},{"key":"985_CR54","first-page":"1","volume":"19","author":"FM Baroody","year":"2007","unstructured":"Baroody FM. Nasal and paranasal sinus anatomy and physiology. Clin Allergy Immunol. 2007;19:1.","journal-title":"Clin Allergy Immunol"},{"issue":"6","key":"985_CR55","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/10611869808997870","volume":"5","author":"S Mathison","year":"1998","unstructured":"Mathison S, Nagilla R, Kompella UB. Nasal route for direct delivery of solutes to the central nervous system: fact or fiction? J Drug Target. 1998;5(6):415\u201341.","journal-title":"J Drug Target"},{"key":"985_CR56","volume-title":"Color textbook of histology e-book","author":"LP Gartner","year":"2006","unstructured":"Gartner LP, Hiatt JL. Color textbook of histology e-book. Philadelphia: Elsevier Health Sciences; 2006."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-0985-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-0985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-0985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T07:31:58Z","timestamp":1571297518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-0985-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-0985-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"8 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The approval forex-vivostudies in animals and human were taken from the \u201cEthical Committee\u201d of Faculty of Pharmacy, B.Z. University Multan under the reference number 104\/PEC\/2016.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval by Ethical Committee"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}